| Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients M Miura, S Satoh, K Inoue, H Kagaya, M Saito, T Inoue, T Suzuki, ... European journal of clinical pharmacology 63, 1161-1169, 2007 | 174 | 2007 |
| Heterocyclic janus kinase 3 inhibitors T Inoue, A Tanaka, K Nakai, H Sasaki, F Takahashi, S Shirakami, ... | 161 | 2007 |
| Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus K Numakura, S Satoh, N Tsuchiya, Y Horikawa, T Inoue, H Kakinuma, ... Transplantation 80 (10), 1419-1424, 2005 | 138 | 2005 |
| Vimentin intermediate filament and plectin provide a scaffold for invadopodia, facilitating cancer cell invasion and extravasation for metastasis MS Yoneyama, S Hatakeyama, T Habuchi, T Inoue, T Nakamura, T Funyu, ... European journal of cell biology 93 (4), 157-169, 2014 | 106 | 2014 |
| A high‐fat diet enhances proliferation of prostate cancer cells and activates MCP‐1/CCR2 signaling M Huang, S Narita, K Numakura, H Tsuruta, M Saito, T Inoue, Y Horikawa, ... The Prostate 72 (16), 1779-1788, 2012 | 79 | 2012 |
| Prognostic significance of HIF‐1α polymorphisms in transitional cell carcinoma of the bladder J Nadaoka, Y Horikawa, M Saito, T Kumazawa, T Inoue, S Narita, T Yuasa, ... International journal of cancer 122 (6), 1297-1302, 2008 | 75 | 2008 |
| Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome M Huang, S Narita, N Tsuchiya, Z Ma, K Numakura, T Obara, H Tsuruta, ... Carcinogenesis 32 (11), 1589-1596, 2011 | 70 | 2011 |
| CYP3A5 *1 allele associated with tacrolimus trough concentrations but not subclinical acute rejection or chronic allograft nephropathy in Japanese renal transplant … S Satoh, M Saito, T Inoue, H Kagaya, M Miura, K Inoue, A Komatsuda, ... European journal of clinical pharmacology 65, 473-481, 2009 | 67 | 2009 |
| Comparison of pharmacokinetics and pharmacogenetics of once-and twice-daily tacrolimus in the early stage after renal transplantation T Niioka, S Satoh, H Kagaya, K Numakura, T Inoue, M Saito, S Narita, ... Transplantation 94 (10), 1013-1019, 2012 | 66 | 2012 |
| Influence of CYP3A5, ABCB1 and NR1I2 polymorphisms on prednisolone pharmacokinetics in renal transplant recipients M Miura, S Satoh, K Inoue, H Kagaya, M Saito, T Inoue, T Habuchi, ... Steroids 73 (11), 1052-1059, 2008 | 65 | 2008 |
| Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility N Kawata, N Tsuchiya, Y Horikawa, T Inoue, H Tsuruta, S Maita, S Satoh, ... International Journal of Cancer 129 (8), 1872-1880, 2011 | 64 | 2011 |
| CA repeat polymorphism in the insulin-like growth factor-I gene is associated with increased risk of prostate cancer and benign prostatic hyperplasia N Tsuchiya, L Wang, Y Horikawa, T Inoue, H Kakinuma, S Matsuura, ... International journal of oncology 26 (1), 225-231, 2005 | 60 | 2005 |
| Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate … Z Ma, N Tsuchiya, T Yuasa, T Inoue, T Kumazawa, S Narita, Y Horikawa, ... International journal of cancer 123 (11), 2574-2579, 2008 | 54 | 2008 |
| Requirement of androgen-dependent activation of protein kinase Cζ for androgen-dependent cell proliferation in LNCaP cells and its roles in transition to androgen-independent cells T Inoue, T Yoshida, Y Shimizu, T Kobayashi, T Yamasaki, Y Toda, ... Molecular Endocrinology 20 (12), 3053-3069, 2006 | 53 | 2006 |
| The influence of mycophenolate mofetil versus azathioprine and mycophenolic acid pharmacokinetics on the incidence of acute rejection and infectious complications after renal … S Satoh, H Tada, M Murakami, N Tsuchiya, T Inoue, H Togashi, ... Transplantation proceedings 37 (4), 1751-1753, 2005 | 53 | 2005 |
| Prevalence of skeletal complications and their impact on survival of hormone refractory prostate cancer patients in Japan T Inoue, T Segawa, T Kamba, K Yoshimura, E Nakamura, H Nishiyama, ... Urology 73 (5), 1104-1109, 2009 | 52 | 2009 |
| Clinical implications of the MDM2 SNP309 and p53 Arg72Pro polymorphisms in transitional cell carcinoma of the bladder Y Horikawa, J Nadaoka, M Saito, T Kumazawa, T Inoue, T Yuasa, ... Oncology reports 20 (1), 49-55, 2008 | 51 | 2008 |
| Correlations between pretransplant dialysis duration, bladder capacity, and prevalence of vesicoureteral reflux to the graft T Inoue, S Satoh, M Saito, K Numakura, H Tsuruta, T Obara, S Narita, ... Transplantation 92 (3), 311-315, 2011 | 50 | 2011 |
| Circadian pharmacokinetics of mycophenolic acid and implication of genetic polymorphisms for early clinical events in renal transplant recipients S Satoh, H Tada, M Murakami, N Tsuchiya, Z Li, K Numakura, M Saito, ... Transplantation 82 (4), 486-493, 2006 | 49 | 2006 |
| Lack of tacrolimus circadian pharmacokinetics and CYP3A5 pharmacogenetics in the early and maintenance stages in Japanese renal transplant recipients S Satoh, H Kagaya, M Saito, T Inoue, M Miura, K Inoue, K Numakura, ... British journal of clinical pharmacology 66 (2), 207-214, 2008 | 48 | 2008 |
